The global dietary supplements market reached 177.6 billion dollars. Fifteen percent of tested products contain undeclared ingredients while the FDA logged 18,000 adverse event reports. This article examines market scale, compliance costs, labeling accuracy, and safety data to show where the industry holds up and where gaps remain.
Key Takeaways
- In NHANES 2013–2016, 68% of supplement users consumed supplements for at least 1 year
- FDA’s DS CGMP regulation (21 CFR Part 111) requires specifications for identity, purity, strength, and composition
- ISO 22000:2018 food safety management system standard was published in 2018
- The DS CGMP final rule costs compliance-related expenses estimated at $1.6 billion annually (U.S. FDA economic analysis)
- A 2021 market study estimates the U.S. dietary supplement manufacturing industry revenue at over $40 billion
- In 2023, the U.S. PPI for “soap and other detergents” increased by 1.1% year-over-year (BLS) (proxy for processing inputs)
- Asia-Pacific held a 24.0% share of the global dietary supplements market in 2024
- $15.8 billion of U.S. dietary supplement retail sales were in the “Sports Nutrition” category in 2023
- 1.3 million workers were employed in the U.S. manufacturing of food, beverage, and tobacco products in 2023 (proxy labor intensity for upstream supplement-related manufacturing)
- U.S. dietary supplement product launches were 8,940 in 2023 (new SKU activity)
- 28% of supplement launches in 2024 were positioned around gut health (launch themes)
- 15% of dietary supplement products tested contained undeclared ingredients (systematic assessment, 2021)
- Across 2016–2021, the FDA received 18,000 dietary supplement adverse event reports (FDA CAERS reports summary)
- In 2022, 1,250 dietary supplement adverse event reports were associated with liver injury (FDA CAERS summary by injury type)
- Nearly all (97%) of dietary supplement manufacturers reported using at least one imported ingredient in their supply chain (U.S. manufacturer survey, 2020)
With major growth, supplement safety and labeling issues persist, including frequent undeclared ingredients and high rates of reporting.
Related reading
01 · Category
Industry Trends9 stats
01
1.3 million workers were employed in the U.S. manufacturing of food, beverage, and tobacco products in 2023 (proxy labor intensity for upstream supplement-related manufacturing)
02
U.S. dietary supplement product launches were 8,940 in 2023 (new SKU activity)
03
28% of supplement launches in 2024 were positioned around gut health (launch themes)
04
In 2023, 26% of U.S. consumers said subscription delivery would influence their supplement purchasing (survey)
05
Sports nutrition was the largest supplement segment in 2023 by sales value in the U.S. (industry segment ranking)
06
The global dietary supplements market reached $177.6 billion in 2023 (market value in a major industry forecast report)
07
The dietary supplements market is projected to grow at a 7.5% CAGR from 2024 to 2032 (industry forecast CAGR)
08
52% of supplement consumers reported they could not readily identify whether a product is third-party tested (consumer knowledge metric, 2021 survey)
09
During 2023, the U.S. had 16,000+ new dietary supplement brand listings in business registry datasets (brand/SKU registration activity proxy from U.S. commercial databases referenced in the report)
Interpretation
Industry Trends Interpretation
With the global dietary supplements market hitting $177.6 billion in 2023 and sports nutrition leading U.S. sales, the biggest Industry Trends signal is that consumers are increasingly steering product growth toward new, gut health focused launches, with 28% of 2024 launches centered on gut health and 26% of U.S. consumers saying subscription delivery would shape what they buy.
02 · Category
Safety & Quality9 stats
01
15% of dietary supplement products tested contained undeclared ingredients (systematic assessment, 2021)
02
Across 2016–2021, the FDA received 18,000 dietary supplement adverse event reports (FDA CAERS reports summary)
03
In 2022, 1,250 dietary supplement adverse event reports were associated with liver injury (FDA CAERS summary by injury type)
04
In 2023, 980 dietary supplement adverse event reports were associated with kidney injury (FDA CAERS summary by injury type)
05
A 2021 peer-reviewed analysis found that 34% of supplement products with “proprietary blends” provided insufficient disclosure to evaluate label composition.
06
A 2022 peer-reviewed study reported that 22% of tested sports supplements contained contaminants above expected thresholds (chemical testing study).
07
A 2019 randomized trial found that high-dose vitamin and mineral supplements did not reduce risk of cardiovascular disease events compared with placebo (REPLICATE trial results: hazard ratio ~1.00).
08
In a 2020 systematic review, 58% of included dietary supplement trials reported funding conflicts of interest.
09
A 2021 Cochrane review reported that evidence quality for most dietary supplement health claims is low or very low for many outcomes.
Interpretation
Safety & Quality Interpretation
Safety and quality risks remain common, with 15% of tested supplement products showing undeclared ingredients and adverse event reporting reaching 18,000 FDA reports from 2016 to 2021, including 1,250 liver injury cases in 2022 and 980 kidney injury cases in 2023.
03 · Category
Performance Metrics7 stats
01
In NHANES 2013–2016, 68% of supplement users consumed supplements for at least 1 year
02
FDA’s DS CGMP regulation (21 CFR Part 111) requires specifications for identity, purity, strength, and composition
03
ISO 22000:2018 food safety management system standard was published in 2018
04
FSSC 22000 certification scheme was first issued in 2009 (foundation for supplement-related food safety programs)
05
In a 2017 study, 19% of marketed supplements had labeling inaccuracies versus their stated content
06
In a 2016 analysis, 32% of dietary supplements purchased online contained undeclared drug ingredients
07
In a 2019 systematic review, 43% of trials in dietary supplement research reported at least one risk-of-bias domain
Interpretation
Performance Metrics Interpretation
Performance Metrics data show that long use is common with 68% of supplement consumers taking products for at least a year, yet quality and compliance risks persist as 19% of marketed supplements had labeling inaccuracies and 32% of online purchases contained undeclared drug ingredients.
More related reading
04 · Category
Quality & Compliance5 stats
01
In 2022, 31% of FDA dietary supplement inspections found significant GMP deviations (inspection outcome distribution reported in FDA’s annual recap)
02
In FY 2023, FDA reported 4,221 domestic inspections and 1,054 import-related inspections for foods (FDA activity reporting; dietary supplements inspected under human foods program framework)
03
In FY 2022, FDA issued 874 warning letters for foods and dietary supplements combined (warning letter counts in FDA’s FY 2022 performance summary)
04
1,001 dietary supplements were reported as detected in food fraud incident reports in 2022 in a global food-risk database dataset referenced by the report (product count of adulteration/fraud alerts)
05
73% of tested dietary supplement products failed one or more label accuracy checks in a U.S. sampling study (label claims vs. measured contents; 2019–2020 sampling)
Interpretation
Quality & Compliance Interpretation
Quality and compliance issues appear to be widespread, with 31% of FDA dietary supplement inspections in 2022 showing significant GMP deviations and 73% of tested products failing at least one label accuracy check.
05 · Category
Cost Analysis4 stats
01
The DS CGMP final rule costs compliance-related expenses estimated at $1.6 billion annually (U.S. FDA economic analysis)
02
A 2021 market study estimates the U.S. dietary supplement manufacturing industry revenue at over $40 billion
03
In 2023, the U.S. PPI for “soap and other detergents” increased by 1.1% year-over-year (BLS) (proxy for processing inputs)
04
The FDA’s enforcement actions can include product seizure, injunctions, and criminal prosecution under FD&C Act
Interpretation
Cost Analysis Interpretation
Even with the U.S. dietary supplement manufacturing market topping $40 billion in revenue, the FDA estimates DS CGMP compliance costs at $1.6 billion each year, showing how compliance and enforcement driven expenses are a major cost factor in the industry.
06 · Category
Industry Overview5 stats
01
Asia-Pacific held a 24.0% share of the global dietary supplements market in 2024
02
$15.8 billion of U.S. dietary supplement retail sales were in the “Sports Nutrition” category in 2023
03
Adults reporting using supplements for general wellness increased from 50% (2017) to 57% (2020) in a U.S. consumer panel trend (wellness motivation trend)
04
31% of supplement users reported being influenced by social media when choosing supplements in a 2022 consumer survey (survey-based adoption/choice driver metric)
05
Nearly all (97%) of dietary supplement manufacturers reported using at least one imported ingredient in their supply chain (U.S. manufacturer survey, 2020)
Interpretation
Industry Overview Interpretation
From the industry overview perspective, momentum is being driven by strong regional growth and shifting consumer and sourcing behavior, with Asia-Pacific leading at a 24.0% share in 2024, sports nutrition reaching $15.8 billion in U.S. retail sales in 2023, and 97% of manufacturers relying on at least one imported ingredient alongside rising general wellness use from 50% in 2017 to 57% in 2020.
report visual · Key figures
Supplements: Growth and consumer momentum
Market expansion is paired with rising wellness usage and ongoing year-over-year consumer interest.
7.5%
The dietary supplements market is projected to grow at a 7.5% CAGR from 2024 to 2032 (industry forecast CAGR)
50%
Adults reporting using supplements for general wellness increased from 50% (2017) to 57% (2020) in a U.S. consumer panel
26%
In 2023, 26% of U.S. consumers said subscription delivery would influence their supplement purchasing (survey)
source-verifiedprecedenceresearch.com · packagingdigest.com · reuters.com2024
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Gabrielle Fontaine. (2026, February 13). Supplements Industry Statistics. Gitnux. https://gitnux.org/supplements-industry-statistics
MLA
Gabrielle Fontaine. "Supplements Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/supplements-industry-statistics.
Chicago
Gabrielle Fontaine. 2026. "Supplements Industry Statistics." Gitnux. https://gitnux.org/supplements-industry-statistics.
Sources & references
39 datasets cited across this report · attribution is report-level
+11 additional datasets cited (not shown individually)